Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jennifer M. Grimm"'
Publikováno v:
PLoS Pathogens, Vol 11, Iss 12, p e1005286 (2015)
Epstein-Barr virus (EBV) is a human herpesvirus that causes acute infectious mononucleosis and is associated with cancer and autoimmune disease. While many studies have been performed examining acute disease in adults following primary infection, lit
Externí odkaz:
https://doaj.org/article/169c251f195d42acbfbe3336f8d15bfc
Autor:
Emma A. Filtz, Mark D. Rabinovitch, Jennifer M. Grimm-Geris, Laurel E. Cederberg, Henry H. Balfour, David O. Schmeling, Lawrence M. Condon
Publikováno v:
Clinical Infectious Diseases. 68:306-312
Background A potential source of primary Epstein-Barr virus (EBV) infection for young children is parental oral secretions. If parents who identify with racial/ethnic categories other than white have a higher prevalence of oral EBV DNA, this differen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84937ba2ed7bc495ec6bc3857fb60d48
https://doi.org/10.1093/cid/ciy464
https://doi.org/10.1093/cid/ciy464
Publikováno v:
Pediatr Res
The worldwide burden of disease due to Epstein-Barr virus (EBV) infection is enormous. Diseases include endemic Burkitt lymphoma, infectious mononucleosis, cancers after transplantation, Hodgkin lymphoma, and nasopharyngeal carcinoma. A prophylactic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e4703c351d159bb38ec7bb49b372ed3
https://pubmed.ncbi.nlm.nih.gov/31641280
https://pubmed.ncbi.nlm.nih.gov/31641280
Autor:
Jennifer M. Grimm-Geris, Shalini L Kulasingam, David O. Schmeling, Samantha K. Dunmire, L. M. Duval, H. J. Leuschen, Emma A. Filtz, Henry H. Balfour
Publikováno v:
Epidemiology and Infection
Prophylactic vaccines against Epstein–Barr virus (EBV) are under development. EBV-naïve college freshmen are ideal candidates for an efficacy trial, because their incidence of infectious mononucleosis (mono) during freshman year is as high as 20%.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::987f6c5c7717c7f84ec4233b6e3b1922
http://europepmc.org/articles/PMC6518790
http://europepmc.org/articles/PMC6518790
Autor:
Henry H. Balfour, David O. Schmeling, Emma A. Filtz, Arthur J. Matas, Jennifer M. Grimm, Priya S. Verghese
Publikováno v:
Clinical transplantation. 31(11)
Epstein-Barr virus (EBV) poses a significant threat to patient and graft survival posttransplant. We hypothesized that recipients who shed EBV at transplant had less immunologic control of the virus and hence were more likely to have active EBV infec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48188e5270ca65b5c3910bbb9cc8f0cf
https://pubmed.ncbi.nlm.nih.gov/28915342
https://pubmed.ncbi.nlm.nih.gov/28915342
Autor:
Jennifer M. Grimm
Publikováno v:
Medical Journal of Dr. D.Y. Patil University, Vol 10, Iss 5, Pp 445-446 (2017)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76dea21fc042e6e2451fbb6ba5381752
https://doi.org/10.4103/mjdrdypu.mjdrdypu_66_17
https://doi.org/10.4103/mjdrdypu.mjdrdypu_66_17
Autor:
David O. Schmeling, Samantha K. Dunmire, Richard C. Brundage, Jennifer M. Grimm, Kristin A. Hogquist, Beth D. Mullan, Henry H. Balfour, Julie A. Ed, Jennifer A. Knight
Publikováno v:
Clinical & Translational Immunology
We performed an intensive prospective study designed to obtain as much data as possible on the incubation and early illness periods of primary Epstein–Barr virus (EBV) infection. Undergraduate students who lacked EBV antibody and oral EBV DNA (EBV-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::076ba5b69f12a3ca44d51770422127e1
https://doi.org/10.1038/cti.2016.48
https://doi.org/10.1038/cti.2016.48